| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.02 | 0.7 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |